Mark Aronica
Impact in
- Immunology top 1%
- IL-33, ST2, and ILC Pathways
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Dermatology top 2%
Papers in
- Immunology 27
- Immune Cell Function and Interaction 13
- IL-33, ST2, and ILC Pathways 13
- Immune Response and Inflammation 6
- Physiology 25
- Asthma and respiratory diseases 25
- Co-authors
- Shadi Swaidani (17 shared papers)Xiaoxia Li (14 shared papers)Mark Boothby (9 shared papers)Katarzyna Bulek (8 shared papers)Caini Liu (8 shared papers)Muhammet F. Gülen (6 shared papers)Serpil C. Erzurum (12 shared papers)Ana L. Mora (7 shared papers)
- Journals
- The Journal of Immunology (12 papers)Journal of Biological Chemistry (5 papers)Journal of Allergy and Clinical Immunology (3 papers)Science Signaling (2 papers)Cytokine (2 papers)
- Partner nations
- United StatesPolandUnited Kingdom
In The Last Decade
Mark Aronica
50 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 115
- Immunology 1.5k
- Dermatology 246
- Cancer Research 387
- Immunology and Allergy 152
- Physiology 616
Countries citing papers authored by Mark Aronica
This map shows the geographic impact of Mark Aronica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aronica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aronica more than expected).
Fields of papers citing papers by Mark Aronica
This network shows the impact of papers produced by Mark Aronica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aronica. The network helps show where Mark Aronica may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Aronica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 485 | |
| 2 | 2011 | 166 | |
| 3 | 2006 | 160 | |
| 4 | 2009 | 143 | |
| 5 | Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. | 1999 | 141 |
| 6 | 1999 | 139 | |
| 7 | 2009 | 110 | |
| 8 | 2019 | 103 | |
| 9 | 2008 | 91 | |
| 10 | 2010 | 83 | |
| 11 | 2003 | 82 | |
| 12 | 2011 | 69 | |
| 13 | 2011 | 68 | |
| 14 | 2007 | 65 | |
| 15 | 2017 | 62 | |
| 16 | 2015 | 61 | |
| 17 | 2012 | 59 | |
| 18 | 2016 | 58 | |
| 19 | 2012 | 54 | |
| 20 | 2018 | 52 |
About Mark Aronica
Mark Aronica is a scholar working on Immunology, Physiology, Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 50 papers that have together received 3.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (25 papers), Immune Cell Function and Interaction (13 papers), IL-33, ST2, and ILC Pathways (13 papers), NF-κB Signaling Pathways (8 papers), Proteoglycans and glycosaminoglycans research (8 papers), Immune Response and Inflammation (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Neonatal Respiratory Health Research (4 papers). The work is most often cited by research in Immunology (1.5k citations), Dermatology (246 citations), Cancer Research (387 citations), Immunology and Allergy (152 citations) and Physiology (616 citations). Mark Aronica has collaborated with scholars based in United States, Poland and United Kingdom. Frequent co-authors include Shadi Swaidani, Xiaoxia Li, Mark Boothby, Katarzyna Bulek, Caini Liu, Muhammet F. Gülen, Serpil C. Erzurum, Ana L. Mora, Mark Lauer and James R. Sheller. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Journal of Allergy and Clinical Immunology, Science Signaling and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.